AB

Abivax S.A.

  • CIK: 0001956827
  • EIN: 00-0000000
  • Business address: 7 BD HAUSSMANN, PARIS, France, 75009

Information

  • Mailing address
    7 BD HAUSSMANN, PARIS, France, 75009
  • Phone
    01 53 83 09 63
  • State location
    France
  • State of incorporation
    France
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About Abivax S.A.

Abivax S.A. (CIK: 0001956827) is an American company incorporated in the state of France. Head office is located at 7 BD HAUSSMANN, PARIS, France, 75009. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Abivax S.A. is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Abivax S.A.

Filings Format Description Filed/Effective File/Film Number
SCHEDULE 13G/A Document Acc-no: 0001172661-25-003272 (34 Act) Size: KB Aug-14-2025

005-94198

251214669
SCHEDULE 13D/A Document Acc-no: 0001104659-25-072677 (34 Act) Size: KB Jul-31-2025

005-94198

251171619
424B5 Document

Prospectus filed pursuant to Rule 424(b)(5)

Acc-no: 0001193125-25-164456 (33 Act) Size: KB		 Jul-24-2025

333-288884

251147596
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-25-164414 (34 Act) Size: KB		 Jul-24-2025

001-41842

251147016
FWP Document

Filing under Securities Act Rules 163/433 of free writing prospectuses

Acc-no: 0001193125-25-163923 (34 Act) Size: KB		 Jul-24-2025

333-288884

251144679
FWP Document

Filing under Securities Act Rules 163/433 of free writing prospectuses

Acc-no: 0001193125-25-163539 (34 Act) Size: KB		 Jul-23-2025

333-288884

251143908
424B5 Document

Prospectus filed pursuant to Rule 424(b)(5)

Acc-no: 0001193125-25-163478 (33 Act) Size: KB		 Jul-23-2025

333-288884

251143804
F-3ASR Document

Automatic shelf registration statement of securities of well-known seasoned issuers

Acc-no: 0001193125-25-163402 (33 Act) Size: KB		 Jul-23-2025

333-288884

251143087
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-25-162671 (34 Act) Size: KB		 Jul-22-2025

001-41842

251141045
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001956827-25-000024 (34 Act) Size: KB		 Jun-11-2025

001-41842

251039875
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001956827-25-000021 (34 Act) Size: KB		 Jun-02-2025

001-41842

251014896
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001956827-25-000016 (34 Act) Size: KB		 Apr-29-2025

001-41842

25887082
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-25-089339 (34 Act) Size: KB		 Apr-22-2025

001-41842

25858591
SCHEDULE 13G Document Acc-no: 0000950170-25-053321 (34 Act) Size: KB Apr-11-2025

005-94198

25832745
S-8 Document

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Acc-no: 0001193125-25-061479 (33 Act) Size: KB		 Mar-24-2025

333-286069

25765198
20-F Document

Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d)

Acc-no: 0001956827-25-000010 (34 Act) Size: KB		 Mar-24-2025

001-41842

25764931
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001956827-25-000004 (34 Act) Size: KB		 Mar-24-2025

001-41842

25762125
SCHEDULE 13D/A Document Acc-no: 0001104659-25-014140 (34 Act) Size: KB Feb-14-2025

005-94198

25629189
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-25-004163 (34 Act) Size: KB		 Jan-10-2025

001-41842

25520710
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-24-284298 (34 Act) Size: KB		 Dec-23-2024

001-41842

241574838

Recent 20 filings. View all Abivax S.A. filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Frequently Asked Questions

Tags:

  • Abivax S.A. overview
  • Abivax S.A. job
  • Abivax S.A. stock
  • Abivax S.A. ownership
  • Abivax S.A. CEO
  • Abivax S.A. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

atai Life Sciences Luxembourg S.A.
Update: Sep 23, 2025
Hyperliquid Strategies Inc
Update: Sep 05, 2025
Polaryx Therapeutics, Inc.
Update: Sep 05, 2025
Nasus Pharma Ltd
Update: Jul 10, 2025
Promicell, Inc.
Update: May 30, 2025
Maius Pharmaceutical Group Co., Ltd.
Update: Mar 01, 2025

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1815 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4624 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 2373 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3796 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4740 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1911 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2827 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1670 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2001 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by